Header

On December 8-10, Johnson & Johnson Innovation - JLABS and the Biomedical Advanced Research and Development Authority (BARDA) virtually convened the emerging Blue Knight community of thought leaders, innovators and entrepreneurs for a three-day symposium, including interactive sessions focused on key areas of interest in infectious disease, public health, and company acceleration. Sessions explored high priority areas of interest for scientific and technological innovation aimed for improving our preparedness and response to emerging health security threats. View the full 2020 Symposium Agenda here.

Collaborating to unlock

Keynote: Collaborating to Unlock the Collective Power of the Global Community

Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, opens the first session with a keynote speech.

Watch Video
The vision

Collaborating to Unlock the Collective Power of the Global Community

Setting the tone for the symposium, Johnson & Johnson Innovation – JLABS and BARDA leadership outline the vision and value proposition for the Blue Knight collaboration in the opening session...

Watch Video
Unpacking the Past to Improve

Unpacking the Past to Improve the Future of Pandemic Preparedness

This session will analyze pandemic preparedness infrastructures that existed in the United States and globally prior to the COVID-19 outbreak. Panelists will discuss gaps and lessons learned from the current pandemic...

Watch Video
Keynote 2: Anticipating the known and unknown threats of tomorrow

Keynote: Anticipating the Known and Unknown Threats of Tomorrow

Christopher E. Mason, Ph.D., Associate Professor, Weill Cornell Medicine; Director, WorldQuant Initiative for Quantitative Prediction, opens the Anticipating the Known and Unknown Threats of Tomorrow session with a keynote speech.

Watch Video
Anticipating the Known and Unknown Threats of Tomorrow

Anticipating the Known and Unknown Threats of Tomorrow

Moving past reflection and into action, this session will evaluate the potential changes necessary to effectively combat future pandemics and health threats with urgency and shared purpose...

Watch Video
Advancing Therapeutic and Vaccine Platforms and Technologies

Advancing Therapeutic and Vaccine Platforms and Technologies

During this scientific session, thought leaders will discuss the importance of advancing platform and technology approaches for therapeutic and vaccine innovation to help anticipate, scale and prepare for future infectious disease and other health security threats...

Watch Video
Accelerating Disruptive and Non-Traditional Modalities for Addressing Bacterial Pathogens

Accelerating Disruptive and Non-Traditional Modalities for Addressing Bacterial Pathogens

During this session, expert thought leaders will discuss the development of novel therapies, including the use of phage therapy and CRISPR technology, which may offer the potential benefit of combating bacterial pathogens without increasing antibiotic resistance...

Watch Video
Enabling Point of Care and At Home Diagnostics

Enabling Point of Care and At Home Diagnostics

The future of diagnostics use may move outside of the healthcare setting and into the home, directly into the hands of the consumer...

Watch Video
Ensuring robust data science

Ensuring Robust Data Science

This session will include a discussion of innovations in data science aimed at pushing the boundaries on data capture and analysis, including computational modeling to predict an individual’s response to emerging infectious diseases and other global health

Watch Video
Showcase

BLUE KNIGHT™ Showcase

Watch the Blue Knight Showcase for a deep dive into the “science inside” our portfolio of start-up companies...

Watch Video
Expanding the Shield by Igniting Early-Stage Innovation

Expanding the Shield by Igniting Early-Stage Innovation

During this final plenary session, experts will address key questions innovators face when developing preparedness solutions, including critical milestone setting and what success looks like from the perspective of a potential funder...

Watch Video